Jessica S. Beaver, PHD, MLS
President & Chief Executive Officer
Dr. Beaver has over 20 years of experience in the pharma and medical device industries. Her executive experience ranges across all stages of R&D from product discovery through commercialization. Previous positions include Chief Regulatory Officer, Operations Officer, and Compliance Officer. She was also a practicing pharmacist at the time the opioid crisis was getting started. Her collective experiences are essential in propelling the DispenSecur™ platform to the next level.
Petra Weishaupt-Smith
Chief Financial Officer
Ms. Weishaupt-Smith has over 30 years of experience as a senior financial executive, investor, and business advisor in the technology sector. Her successful exits include A4 Health Systems, Advanced Liquid Logic, Digitalsmiths & WebAssign. Her collective experiences and tenacity are vital to carry Verinetics into the next stage of financing and commercial operations.
Jim Mclean, mba
Chief Technology Officer
Mr. McLean has over 30 years in senior management roles with Fortune 500 and startup organizations, where his particular focus has been the design and successful implementation of creative technology solutions for complex operational challenges. His experience as a team builder in information systems/technology, engineering, sales, and professional services is key to the commercial success of the DispenSecur™ platform.
Dr. Tom Mercolino,PHD
Founder & Chairman
With more than 25 years of experience as a senior manager in Fortune 100 R&D groups, Dr. Mercolino has taken technology commercialization expertise to the next level with Verinetics. His passion for supporting individuals with Opioid Use Disorder (OUD) is the reason for the success of Verinetics.